Biophytis - ADR

NASDAQ:BPTS   3:58:33 PM EDT
0.35
0.00 (+0.29%)
5:49:57 PM EDT: $0.31 -0.04 (-11.37%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Biophytis - ADR Stock, NASDAQ:BPTS

Sorbonne Universit�©, B�¢timent A 4 ��me �©tage, Paris, Ile-de-France 75005
France
Phone: +33.1.44.27.23.00
Number of Employees:

Description

Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and Ren�© Lafont on September 27, 2006 and is headquartered in Paris, France.